Today: 30 April 2026
Tesla stock heads into a big week: $99 FSD push, robotaxi talk and earnings on deck

Tesla stock heads into a big week: $99 FSD push, robotaxi talk and earnings on deck

New York, Jan 24, 2026, 09:58 EST — The market has closed.

  • Tesla shares closed Friday marginally lower, slipping 0.07% to $449.06.
  • Tesla is nudging new buyers in North America toward its $99-per-month Full Self-Driving subscription by removing certain bundled driver-assist features.
  • CEO Elon Musk said he expects regulatory approval for Tesla’s driver-supervised FSD system in Europe as soon as next month, with China following a similar schedule.

Tesla shares ended Friday mostly flat, setting the stage for a headline-packed weekend ahead of the company’s quarterly earnings next week.

Why it matters now: Tesla is doubling down on software and autonomy-related income just as investors seek evidence the company can boost margins without relying on a new surge in car sales.

Timing is another factor. Tesla’s update on Jan. 28 comes during a packed week for major tech earnings and heightened macro risks, which can cause sharp moves in high-valuation stocks.

On Thursday, Tesla removed certain driver-assistance features from new vehicles sold in the U.S. and Canada. Buyers seeking self-steering will now need to subscribe to the $99-per-month Full Self-Driving (Supervised) package.

FSD (Supervised) is Tesla’s term for an advanced driver-assistance system: it can steer and manage certain driving tasks, but the driver must stay alert and the system keeps tabs on them. Autosteer — which helps keep the vehicle centered in its lane on highways — is no longer standard, though Traffic Aware Cruise Control still comes included.

Musk informed customers that the subscription price will increase as features get better, sparking complaints from some owners on social media, Reuters reported.

In Davos, Musk expressed optimism that Tesla might secure regulatory approval in Europe “hopefully next month,” adding that China could see a similar timeline. According to Reuters, a Dutch vehicle authority expects to make a decision on FSD by February. Reuters

According to the same Reuters report, Tesla has kicked off robotaxi rides in Austin, Texas, operating without safety monitors onboard. Shares surged 4.2% on Thursday following social media buzz about the driverless trips, but ended flat on Friday.

The shift toward autonomy also brings significant risks. Regulators have been keeping a close eye on driver-assistance systems, and any delays in approvals—or fresh restrictions following incidents—could slow Tesla’s efforts to ramp up software sales. On top of that, consumer backlash remains a wildcard if key features start disappearing behind a paywall.

Ken Mahoney of Mahoney Asset Management, a Tesla shareholder, emphasized that investors want “credible evidence” on the manufacturing scale and regulatory approval path for Tesla’s Optimus robot plans. His comments highlight how investor focus can pivot swiftly from cars to futuristic promises. Reuters

Tesla is set to release its fourth-quarter results on Jan. 28, followed by a Q&A session. Investors will be digging for news on FSD adoption, changes to North America features, and any new timelines for growth in Europe and China.

Stock Market Today

  • Why Investors Are Focused on Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) Amid Growth and High Insider Ownership
    April 29, 2026, 10:29 PM EDT. Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) has attracted investor attention due to its strong financial performance and insider alignment. The company has delivered a compound annual EPS growth of 19% over the past three years, signaling sustained earnings momentum. Revenue growth and an improved EBIT margin, up by 6.6 percentage points to 11%, underscore operational strength. With insiders owning 78% of the firm, alignment between management and shareholders is notably high, reducing agency risk. Valued at ₹2.5 billion, the company appeals to investors favoring profitable, growing firms over speculative ventures without revenue or profit history. This combination of growth, profitability, and insider confidence makes Vaidya Sane a compelling pick in the Ayurvedic healthcare sector.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Apple stock price: China discounts and India antitrust hearing put AAPL in focus before earnings week
Previous Story

Apple stock price: China discounts and India antitrust hearing put AAPL in focus before earnings week

Exxon stock price: XTO’s Eagle Ford sale push puts XOM in play ahead of key week
Next Story

Exxon stock price: XTO’s Eagle Ford sale push puts XOM in play ahead of key week

Go toTop